title: Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States.
abstract: We conducted a study to determine prevalence of HPV types in oropharyngeal cancers in the United States and establish a prevaccine baseline for monitoring the impact of vaccination. HPV DNA was extracted from tumor tissue samples from patients in whom cancer was diagnosed during 1995-2005. The samples were obtained from cancer registries and Residual Tissue Repository Program sites in the United States. HPV was detected and typed by using PCR reverse line blot assays. Among 557 invasive oropharyngeal squamous cell carcinomas, 72% were positive for HPV and 62% for vaccine types HPV16 or 18. Prevalence of HPV-16/18 was lower in women (53%) than in men (66%), and lower in non-Hispanic Black patients (31%) than in other racial/ethnic groups (68%-80%). Results indicate that vaccines could prevent most oropharyngeal cancers in the United States, but their effect may vary by demographic variables.
authors.forename: Martin
authors.initials: M
authors.lastname: Steinau
authors.forename: Mona
authors.initials: M
authors.lastname: Saraiya
authors.forename: Marc T
authors.initials: MT
authors.lastname: Goodman
authors.forename: Edward S
authors.initials: ES
authors.lastname: Peters
authors.forename: Meg
authors.initials: M
authors.lastname: Watson
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Cleveland
authors.forename: Charles F
authors.initials: CF
authors.lastname: Lynch
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Wilkinson
authors.forename: Brenda Y
authors.initials: BY
authors.lastname: Hernandez
authors.forename: Glen
authors.initials: G
authors.lastname: Copeland
authors.forename: Maria S
authors.initials: MS
authors.lastname: Saber
authors.forename: Claudia
authors.initials: C
authors.lastname: Hopenhayn
authors.forename: Youjie
authors.initials: Y
authors.lastname: Huang
authors.forename: Wendy
authors.initials: W
authors.lastname: Cozen
authors.forename: Christopher
authors.initials: C
authors.lastname: Lyu
authors.forename: Elizabeth R
authors.initials: ER
authors.lastname: Unger
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D052685:Alphapapillomavirus / Q000145:classification*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009959:Oropharyngeal Neoplasms / Q000453:epidemiology* / Q000517:prevention & control / Q000821:virology*; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000517:prevention & control; D053918:Papillomavirus Vaccines; D015995:Prevalence; D062486:Public Health Surveillance; D012042:Registries; D014481:United States / Q000453:epidemiology
chemical_list: D053918:Papillomavirus Vaccines
keywords: HPV typing; United States; archived tissue; cancer; human papillomavirus; oropharyngeal; oropharynx; viruses
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467-75
references.pmid: 15734974
references.citation: Cancer. 2008 Nov 15;113(10 Suppl):3036-46
references.pmid: 18980286
references.citation: Head Neck. 2013 May;35(5):747-55
references.pmid: 22267298
references.citation: MMWR Morb Mortal Wkly Rep. 2012 Apr 20;61:258-61
references.pmid: 22513527
references.citation: Eur J Cancer. 2007 Jan;43(2):415-32
references.pmid: 17079134
references.citation: JAMA. 2012 Feb 15;307(7):693-703
references.pmid: 22282321
references.citation: Cancer. 2008 Nov 15;113(10 Suppl):2841-54
references.pmid: 18980203
references.citation: Clin Lab. 2012;58(1-2):61-6
references.pmid: 22372346
references.citation: Oral Oncol. 2009 Apr-May;45(4-5):309-16
references.pmid: 18804401
references.citation: J Low Genit Tract Dis. 2013 Oct;17(4):397-403
references.pmid: 23609590
references.citation: Semin Oncol. 2004 Dec;31(6):744-54
references.pmid: 15599852
references.citation: N Engl J Med. 2007 May 10;356(19):1944-56
references.pmid: 17494927
references.citation: Arch Otolaryngol Head Neck Surg. 2011 Sep;137(9):910-4
references.pmid: 21930979
references.citation: Annu Rev Pathol. 2009;4:49-70
references.pmid: 18729723
references.citation: Cancer Causes Control. 2011 May;22(5):753-63
references.pmid: 21380619
references.citation: J Clin Oncol. 2008 Feb 1;26(4):612-9
references.pmid: 18235120
references.citation: J Mol Diagn. 2011 Jul;13(4):377-81
references.pmid: 21704270
references.citation: J Clin Oncol. 2011 Nov 10;29(32):4294-301
references.pmid: 21969503
references.citation: Int J Cancer. 2010 Apr 15;126(8):1882-1894
references.pmid: 19795456
references.citation: PLoS One. 2012;7(3):e34044
references.pmid: 22479516
references.citation: J Low Genit Tract Dis. 2012 Oct;16(4):471-9
references.pmid: 22652576
references.citation: Lancet Oncol. 2012 Jun;13(6):607-15
references.pmid: 22575588
references.citation: Cancer. 2008 Nov 15;113(10 Suppl):2901-9
references.pmid: 18980273
references.citation: J Natl Cancer Inst. 2008 Feb 20;100(4):261-9
references.pmid: 18270337
references.citation: J Clin Virol. 2013 Jan;56(1):72-6
references.pmid: 23092620
references.citation: Cancer Prev Res (Phila). 2009 Sep;2(9):776-81
references.pmid: 19641042
references.citation: Biochem J. 2012 Apr 15;443(2):339-53
references.pmid: 22452816
references.citation: Int J Cancer. 2012 Sep 1;131(5):1179-86
references.pmid: 22020866
references.citation: J Pathol. 1999 Sep;189(1):12-9
references.pmid: 10451482
references.citation: PLoS One. 2013 Jul 17;8(7):e68329
references.pmid: 23873171
references.citation: Cancer Causes Control. 2000 Jul;11(6):489-95
references.pmid: 10880031
references.citation: J Clin Microbiol. 2012 May;50(5):1539-44
references.pmid: 22357500